VEO Diagnostics, based in Loveland, OH, announced the launch of a serology test – ACCEL-ELISA, which is manufactured by Plexense, based in South Korea.
VEO has sole distribution rights in the United States to ACCEL ELISA, which is a microplate-based enzyme linked immunosorbent assay intended for the qualitative detection of total antibodies (including IgG, IgM, and IgA) to SARS-CoV-2 in human serum.
